Nu Skin Enterprises (NYSE:NUS) issued an update on its FY18 earnings guidance on Thursday morning. The company provided earnings per share guidance of $3.45-3.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.66. The company issued revenue guidance of $2.44-2.49 billion, compared to the consensus revenue estimate of $2.36 billion.Nu Skin Enterprises also updated its Q1 guidance to $0.65-0.70 EPS.

Shares of Nu Skin Enterprises (NYSE NUS) traded up $2.58 during mid-day trading on Thursday, hitting $72.77. 664,526 shares of the company were exchanged, compared to its average volume of 338,270. The stock has a market cap of $3,601.79, a PE ratio of 26.66, a P/E/G ratio of 2.13 and a beta of 1.46. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises has a 12 month low of $47.10 and a 12 month high of $74.45.

NUS has been the topic of a number of recent research reports. ValuEngine upgraded shares of Nu Skin Enterprises from a hold rating to a buy rating in a research note on Sunday, December 31st. Citigroup restated a buy rating and set a $81.00 price target (up from $70.00) on shares of Nu Skin Enterprises in a research note on Tuesday, January 23rd. Finally, Zacks Investment Research cut shares of Nu Skin Enterprises from a hold rating to a sell rating in a research note on Wednesday, December 20th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company. The company presently has an average rating of Hold and a consensus target price of $65.38.

In other Nu Skin Enterprises news, Chairman Steven Lund sold 13,978 shares of the stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $70.01, for a total value of $978,599.78. Following the sale, the chairman now directly owns 4,769 shares in the company, valued at approximately $333,877.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 195,978 shares of company stock worth $13,512,733 over the last quarter. Corporate insiders own 5.20% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The correct version of this article can be read at

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with's FREE daily email newsletter.